THE MCMANUS GROUP for EMD SERONO, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 19, 2018 | $50,000 | Replaced |
| 3rd Quarter - Amendment | Jan 11, 2022 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRYAN CRONAN New | — |
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Health Issues HCR
General pharmaceutical coverage and reimbursement issues, health exchange policy; issues and activities affecting oncology, neurodegenerative and fertility products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.